BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 31, 2010
View Archived Issues
DermaPrep-delivered LC-002 shows promise in phase I/II trials in HIV
Read More
Preclinical and clinical data presented on BEZ-235
Read More
Efficacy and safety data from ECHO and THRIVE trials of rilpivirine reported
Read More
CADA blocks HIV entry by disrupting translocation of CD4 across ER membrane
Read More
HER2-Affitoxin is a potential therapeutic for HER2-overexpressing tumors
Read More
Repros Therapeutics submits analyzed data on Androxal to FDA
Read More
C3 Bio claims new inhibitors of proliferation of vascular smooth muscle cells
Read More
Merz Pharma patents novel NMDA receptor antagonists
Read More
Boehringer Ingelheim Pharma describes new 11-beta-HSD1 inhibitors
Read More
New antagonists of protease-activated PAR1 receptor presented
Read More
BioCancell Therapeutics completes preclinical studies of BC-821 for glioblastoma
Read More
Actavis launches risedronate in four European countries
Read More
Pfizer to purchase Akorn-Strides joint venture product portfolio
Read More
Transgenomic closes acquisition of Clinical Data's diagnostic business
Read More
Swedish Orphan Biovitrum returns rights to rozrolimupab to Symphogen
Read More
FDA approves Fortesta for hypogonadism
Read More
Meta-analysis data reported on pridopidine in Huntington's disease
Read More
Medimmune begins phase Ib/II trial of MEDI-575 in NSCLC
Read More
Compugen enters into funding agreement with Baize Investments
Read More
Immatics Biotech begins phase III IMA-901 trial in renal cell carcinoma
Read More
Axis-Shield provides update on Afinion albumin/creatinine ratio test
Read More
FG-3019 moves into phase II testing for idiopathic pulmonary fibrosis
Read More
Recordati and Merck Serono to comarket pitavastatin calcium in France
Read More
Concert Pharmaceuticals presents new deuterated NS3/NS4A protease inhibitors
Read More